Drug class
Intravenous iron(III)-dextran complex; parenteral iron replacement agent
Mechanism of action
A colloidal iron(III)-hydroxide core complexed with dextran. After administration, iron is taken up by reticuloendothelial cells and released for transferrin binding and incorporation into haemoglobin and iron stores; it is not a simple dissociating iron salt.
General use cases
- Treatment of documented iron deficiency in adults and paediatric patients aged 4 months and older who cannot tolerate oral iron or have had an unsatisfactory response to oral iron; formulation-specific test-dose and hypersensitivity precautions apply
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
